# PLAC8

## Overview
PLAC8, or placenta-specific 8, is a gene that encodes a cysteine-rich protein known as placenta associated 8. This protein is involved in a variety of cellular processes, including differentiation, proliferation, and apoptosis, and is particularly significant in immune cells such as phagocytes, macrophages, and neutrophils. PLAC8 plays a crucial role in the regulation of brown fat differentiation and thermoregulation, influencing key transcription factors necessary for adipocyte differentiation. In the context of cancer, PLAC8 is a central mediator of tumor progression, interacting with critical signaling pathways such as the PI3K/AKT/NF-κB pathway and influencing processes like epithelial-to-mesenchymal transition (EMT) in various cancer types. Its expression and interactions are context-dependent, with roles that can vary from tumor suppression to promoting tumor growth, highlighting its complex involvement in cellular and disease processes (CabreiraCagliari2018Revising; JimenezPreitner2012Plac8; Mao2019PLCA8; Li2014Excess).

## Function
PLAC8, also known as placenta-specific 8, encodes a cysteine-rich protein involved in various cellular processes, including differentiation, proliferation, and apoptosis. In healthy human cells, PLAC8 is highly expressed in phagocytes, macrophages, and neutrophils, where it is essential for optimal bacterial killing. It plays a role in differentiation, proliferation, and apoptosis in myeloid cells, linking primary oncogenic mutations to autophagy induction (CabreiraCagliari2018Revising).

PLAC8 is a critical upstream regulator of brown fat differentiation and thermoregulation. It influences the expression of key transcription factors such as C/EBPb, Krox20, and Klf4, which are essential for adipocyte differentiation. In vitro studies show that PLAC8 is necessary for the differentiation of 3T3-L1 adipocytes, and its knockdown prevents differentiation (JimenezPreitner2012Plac8).

In the context of cancer, PLAC8 acts as a central mediator of tumor progression, particularly in pancreatic ductal adenocarcinoma. It can suppress p53 expression, and its expression is influenced by p53 mutation and Ras activation. In healthy cells, PLAC8's role is context-dependent, as it can protect against apoptosis in fibroblasts and induce apoptosis in human lymphocytes (CabreiraCagliari2018Revising).

## Clinical Significance
The PLAC8 gene is implicated in various cancers, with its expression levels and interactions playing significant roles in disease progression. In lung cancer, elevated PLAC8 levels are associated with larger tumor size, higher histological grade, and advanced tumor node metastasis stage, leading to poorer patient outcomes (Jia2018The). In colorectal cancer, PLAC8 overexpression correlates with increased tumor cell growth and invasion, and is linked to an unconventional epithelial-mesenchymal transition (EMT) through ERK2-dependent pathways (Li2014Excess). 

In pancreatic ductal adenocarcinoma, PLAC8 is strongly expressed in cancer cells and is involved in cell-cycle regulatory pathways, contributing to disease progression (Kaistha2016PLAC8). Conversely, in hepatocellular carcinoma, PLAC8 acts as a tumor suppressor, with its down-regulation associated with poor prognosis and increased cell proliferation (Zou2016Downregulated). 

PLAC8 also plays a role in nasopharyngeal carcinoma, where its upregulation is linked to increased migration and invasion of cancer cells via the TGF-β/Smad pathway (Huang2019Placenta). In renal clear cell carcinoma, PLAC8 is overexpressed and associated with poor prognosis, influencing tumorigenesis and immune response (Sun2023PLAC8). These findings highlight PLAC8's complex and context-dependent role in cancer.

## Interactions
PLAC8, also known as placenta associated 8, is involved in various protein interactions that influence cellular processes. In the context of cancer, PLAC8 interacts with the phosphatidylinositol 3-kinases (PI3K)/protein kinase B (AKT) signaling pathway, which is crucial for cell growth and survival. This interaction is significant in breast cancer, where PLAC8 modulates the PI3K/AKT/NF-κB pathway, affecting cell proliferation and apoptosis (Mao2019PLCA8).

PLAC8 also interacts with dual-specificity phosphatase 6 (DUSP6), inhibiting its phosphatase activity. This inhibition leads to increased phosphorylation of ERK2, promoting an epithelial-to-mesenchymal transition (EMT) in colon cancer cells (Li2014Excess). The interaction with DUSP6 is confirmed through coimmunoprecipitation and yeast two-hybrid analysis (Li2014Excess).

In pancreatic cancer, PLAC8 localizes to the inner face of the plasma membrane and interacts with stable membranous structures, influencing cell growth and disease progression through cell-cycle regulatory pathways (Kaistha2016PLAC8). These interactions highlight PLAC8's role in modulating key signaling pathways and cellular processes across different cancer types.


## References


[1. (JimenezPreitner2012Plac8) Maria Jimenez-Preitner, Xavier Berney, and Bernard Thorens. Plac8 is required for white adipocyte differentiation in vitro and cell number control in vivo. PLoS ONE, 7(11):e48767, November 2012. URL: http://dx.doi.org/10.1371/journal.pone.0048767, doi:10.1371/journal.pone.0048767. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0048767)

[2. (Jia2018The) Yunlu Jia, Xiaogang Ying, Jichun Zhou, Yongxia Chen, Xiao Luo, Shudu Xie, Qin chuan Wang, Wenxian Hu, and Linbo Wang. The novel klf4/plac8 signaling pathway regulates lung cancer growth. Cell Death &amp; Disease, May 2018. URL: http://dx.doi.org/10.1038/s41419-018-0580-3, doi:10.1038/s41419-018-0580-3. This article has 41 citations.](https://doi.org/10.1038/s41419-018-0580-3)

[3. (Li2014Excess) Cunxi Li, Haiting Ma, Yang Wang, Zheng Cao, Ramona Graves-Deal, Anne E. Powell, Alina Starchenko, Gregory D. Ayers, Mary Kay Washington, Vidya Kamath, Keyur Desai, Michael J. Gerdes, Lila Solnica-Krezel, and Robert J. Coffey. Excess plac8 promotes an unconventional erk2-dependent emt in colon cancer. Journal of Clinical Investigation, 124(5):2172–2187, April 2014. URL: http://dx.doi.org/10.1172/jci71103, doi:10.1172/jci71103. This article has 99 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci71103)

[4. (CabreiraCagliari2018Revising) Caroline Cabreira-Cagliari, Nathalia de Cassia Dias, Bianca Bohn, David Gabriel dos Santos Fagundes, Marcia Margis-Pinheiro, Maria Helena Bodanese-Zanettini, and Alexandro Cagliari. Revising the plac8 gene family: from a central role in differentiation, proliferation, and apoptosis in mammals to a multifunctional role in plants. Genome, 61(12):857–865, December 2018. URL: http://dx.doi.org/10.1139/gen-2018-0035, doi:10.1139/gen-2018-0035. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1139/gen-2018-0035)

[5. (Mao2019PLCA8) Misha Mao, Yongxia Chen, Yunlu Jia, Jingjing Yang, Qun Wei, Zhaoqing Li, Lini Chen, Cong Chen, and Linbo Wang. Plca8 suppresses breast cancer apoptosis by activating the pi3k/akt/nf‐κb pathway. Journal of Cellular and Molecular Medicine, 23(10):6930–6941, August 2019. URL: http://dx.doi.org/10.1111/jcmm.14578, doi:10.1111/jcmm.14578. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.14578)

[6. (Huang2019Placenta) Mao-Ling Huang, You Zou, Rui Yang, Yang Jiang, Jian-Fei Sheng, Ji-Bo Han, Yong-Gang Kong, Ze-Zhang Tao, and Shi-Ming Chen. Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the tgf-β/smad pathway. Experimental Cell Research, 374(1):172–180, January 2019. URL: http://dx.doi.org/10.1016/j.yexcr.2018.11.021, doi:10.1016/j.yexcr.2018.11.021. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2018.11.021)

[7. (Sun2023PLAC8) Xu Sun, Zhanpeng Liu, Qian Yu, Yinwei Chen, Yunwen Sun, Qingyi Zhu, Jian Yang, and Rongjiang Jiang. Plac8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma. Frontiers in Oncology, October 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1207551, doi:10.3389/fonc.2023.1207551. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1207551)

[8. (Kaistha2016PLAC8) Brajesh P. Kaistha, Holger Lorenz, Harald Schmidt, Bence Sipos, Michael Pawlak, Berthold Gierke, Ramona Kreider, Brigitte Lankat-Buttgereit, Melanie Sauer, Lisa Fiedler, Anja Krattenmacher, Bettina Geisel, Johann M. Kraus, Kristopher K. Frese, Sabine Kelkenberg, Nathalia A. Giese, Hans A. Kestler, Thomas M. Gress, and Malte Buchholz. Plac8 localizes to the inner plasma membrane of pancreatic cancer cells and regulates cell growth and disease progression through critical cell-cycle regulatory pathways. Cancer Research, 76(1):96–107, January 2016. URL: http://dx.doi.org/10.1158/0008-5472.CAN-15-0216, doi:10.1158/0008-5472.can-15-0216. This article has 70 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-15-0216)

[9. (Zou2016Downregulated) Lei Zou, Jie Chai, Yang Gao, Jie Guan, Qi Liu, and Jia-Jun Du. Down-regulated plac8 promotes hepatocellular carcinoma cell proliferation by enhancing pi3k/akt/gsk3β/wnt/β-catenin signaling. Biomedicine &amp; Pharmacotherapy, 84:139–146, December 2016. URL: http://dx.doi.org/10.1016/j.biopha.2016.09.015, doi:10.1016/j.biopha.2016.09.015. This article has 41 citations.](https://doi.org/10.1016/j.biopha.2016.09.015)